公开(公告)号：US20140155382A1

公开(公告)日：2014-06-05

申请号：US14087480

申请日：2013-11-22

Applicant: ABBVIE INC.

Inventor： David A. DEGOEY ,  Allan C. KRUEGER ,  Charles W. HUTCHINS ,  Warren M. KATI ,  William A. CARROLL

IPC: A61K31/55 ,  A61K31/422 ,  A61K31/4184 ,  A61K31/4178 ,  A61K45/06 ,  C07D487/04 ,  C07D417/14 ,  C07D413/12 ,  C07D403/14 ,  C07D207/16 ,  A61K31/506 ,  A61K31/4025

CPC classification number: A61K31/55 ,  A61K31/4025 ,  A61K31/4178 ,  A61K31/4184 ,  A61K31/422 ,  A61K31/506 ,  A61K38/00 ,  A61K45/06 ,  C07D205/04 ,  C07D207/16 ,  C07D207/22 ,  C07D209/52 ,  C07D211/60 ,  C07D263/06 ,  C07D277/06 ,  C07D401/14 ,  C07D403/12 ,  C07D403/14 ,  C07D405/14 ,  C07D413/12 ,  C07D413/14 ,  C07D417/14 ,  C07D487/04 ,  C07K5/06034 ,  C07K5/06043 ,  C07K5/0606 ,  C07K5/06069 ,  C07K5/06078 ,  C07K5/06139

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.